The Food and Drug Administration issued draft guidance Thursday on clinical trials for early-stage Alzheimer's drugs.
Botox may be more synonymous with the Real Housewives reality franchise than long-term care residents, but it could soon be a treatment of choice for urinary incontinence.
A new method for safely inducing short-term hearing loss in people might be a breakthrough in developing hearing loss prevention drugs, investigators say.
More than 100 medicines now appear on the government's drug shortage list. Those most often in short supply include anesthetics and oncological drugs, according to the Food & Drug Administration. Experts cite several reasons for the ongoing dearth of needed medicines.
A medical device excise tax scheduled to hit Jan. 1 is causing uncertainty among manufacturers and providers, a healthcare expert recently noted. The 2.3% tax will affect sales of Food & Drug Administration-approved devices that are used by a physician or in a physician's office.
There is no way to tally the full cost of Alzheimer's disease, a life robbing condition that now claims more than 5 million victims nationwide. But what can be put on a ledger sheet is sobering. Alzheimer's disease is now responsible for a quarter of all claims for nursing home services.